Recursion Pharmaceuticals, Inc.
RXRX · Small Cap · NASDAQ · Healthcare · Biotechnology
$3.33−$0.11 (-3.20%)
Free research brief
Get the full brief on RXRX
Free to track. No card required.
Where RXRX sits today
Price, momentum, and the numbers behind the story.
RSI (14)
51.1Neutral
03070100
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$3.33
Lowest
$4
Median target
$7
Highest
$10
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Revenue
✓ Good things about the company
Debt / equity
Strong · Low debt, strong balance
0.07x
Current ratio
Strong · Good liquidity position
5.03x
⚠ Things to watch
Price / sales
Rich · Overpriced by revenue
32.65x
ROIC
Weak · Weak capital efficiency
-34.6%
ROE
Weak · Weak shareholder returns
-56.6%
How it stacks up against its peers
RXRX against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $1.79B | - | -15.1% | - |
 | $34.27B | 35.9 | +15.5% | 78 |
 | $11.14B | 21.2 | +19.7% | 78 |
 | $4.12B | 12.4 | +13.5% | 77 |
 | $1.11T | 39.9 | +49.6% | 76 |